Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2001 December;92(6) > Minerva Medica 2001 December;92(6):417-20

CURRENT ISSUEMINERVA MEDICA

A Journal on Internal Medicine


Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,236


eTOC

 

ORIGINAL ARTICLES  


Minerva Medica 2001 December;92(6):417-20

language: Italian

Intramuscular injection of disodium-clodronate in patients with rheumatoid arthritis. A two-month open study

Rovetta G., Monteforte P., Molfetta L


PDF  REPRINTS


Background. The aim of the study was to evaluate the effect on articular pain of 100 mg of disodium-clodronate administered daily by intramuscular injection in patients affected by rheumatoid arthritis.
Methods. We studied 24 patients with established rheumatoid arthritis, in the II and III stage according to Steinbrocker. Visual analogue pain scale, physician global assessment activity and patient global assessment activity were recorded at baseline, after 30 days and after 60 days of treatment.
Results. VAS significant improvement after 30 days was found. The physician and patient global assessment activity were improved after 60 days of treatment.
Conclusions. Disodium-clodronate given by intramuscular injection at the dose of 100 mg/die in rheumatoid patients vas effective in relieving joint pain during a two-month observation.

top of page